GO	[-7.27 -0.59]	[-0.59 -0.26]	[-0.26 -0.13]	[-0.13 -0.04]	[-0.04 0.00]	[0.00 0.00]	[0.00 0.08]	[0.08 0.21]	[0.21 0.45]	[0.45 0.94]	[0.94 8.92]
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	0.781	-1.027	-3.591	-4.910	1.765	8.989	-1.528	-3.060	-1.259	-0.301	4.194
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-1.615	0.783	-0.866	-2.332	-6.360	-4.558	0.389	0.293	1.797	2.918	6.822
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-3.038	-0.276	-1.086	-0.664	-2.064	-4.411	-0.855	-1.086	4.900	2.665	6.259
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.431	0.914	-1.996	-0.898	-1.366	-3.937	-2.830	-1.114	0.914	2.842	9.655
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.828	0.301	-0.828	-0.828	-2.191	-5.744	-1.027	0.396	0.507	3.485	7.540
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	1.463	-3.684	-3.147	-1.905	1.065	1.926	0.474	-3.684	-1.315	2.741	3.055
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.398	0.310	0.310	-0.889	-1.731	-6.650	-2.116	0.310	1.046	1.730	6.594
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	-0.405	-0.301	-4.925	-1.361	0.818	-0.689	-1.099	-1.099	-0.877	2.160	9.229
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-2.820	-1.519	-1.882	-0.424	0.399	-5.064	-0.424	1.037	4.468	1.484	2.316
XIE_LT_HSC_S1PR3_OE_UP XIE_LT_HSC_S1PR3_OE_UP	0.302	-1.201	-1.201	-1.201	-1.201	-1.201	-0.300	-0.610	-1.201	3.824	6.336
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	0.330	-1.641	0.330	-1.093	-0.714	-0.452	-1.641	-1.641	-1.093	0.756	11.645
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-0.597	-0.430	0.959	-0.597	-1.407	-3.751	-1.815	-2.318	0.755	5.825	3.111
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	-0.533	-1.099	-2.921	-2.439	1.406	5.346	-0.877	-3.482	0.402	0.818	2.762
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-1.555	-0.621	-1.901	-1.009	0.345	-3.969	-0.621	-1.009	1.781	4.397	4.813
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-1.273	-0.430	-1.273	-0.767	-1.607	-3.760	-0.580	-0.580	1.298	3.468	6.596
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.896	-0.728	-0.572	-0.572	-1.680	-2.020	-1.386	-1.680	0.360	0.736	11.216
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	0.771	-0.767	-3.900	-1.852	-0.767	0.364	-1.511	-1.221	0.616	1.840	7.705
KEGG_ECM_RECEPTOR_INTERACTION KEGG_ECM_RECEPTOR_INTERACTION	0.451	-0.671	-1.835	-1.835	-2.510	-0.957	-0.671	-0.957	0.636	2.886	7.227
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	1.612	-1.117	-1.117	-2.467	-0.415	1.612	-1.382	-2.951	-1.382	2.714	4.886
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-2.166	0.405	-1.011	-0.814	-2.166	-4.168	0.649	-0.294	0.962	2.042	6.245
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	0.560	-0.375	-2.832	-2.358	-1.045	0.434	-1.600	-1.950	0.706	3.912	5.114
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	0.578	-0.292	-0.566	-1.002	-3.297	-3.297	-1.002	-0.412	-0.292	4.626	4.638
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	2.658	-1.433	-1.433	-0.568	1.080	3.473	-1.433	-3.220	-1.888	-0.568	2.666
NABA_ECM_AFFILIATED NABA_ECM_AFFILIATED	1.456	-1.623	-2.385	-1.063	-0.385	0.691	-2.385	-1.063	-1.063	3.502	5.056
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.104	1.510	-0.528	-0.528	-2.623	-4.945	-1.859	-1.044	1.739	1.983	2.253
REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	2.780	-0.500	-1.575	-1.575	-0.500	-0.893	-0.266	-0.893	-1.575	0.339	6.340
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	0.318	0.423	-0.385	-2.385	-3.418	-1.623	-0.845	-0.845	0.853	2.227	6.375
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	0.599	1.592	-1.317	-1.048	-2.975	-4.338	-0.635	-0.482	2.130	0.934	3.444
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	-0.402	0.421	-2.255	-2.758	-0.921	-0.541	-0.921	-0.402	0.554	0.708	9.055
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-1.382	0.510	-0.545	0.392	-4.962	-4.175	0.646	0.976	0.510	2.128	2.421
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	-0.517	-1.027	-0.828	-3.060	1.535	5.331	0.507	-2.191	-1.027	-0.659	2.565
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-2.280	-1.287	-0.513	-0.392	-0.836	-4.488	-0.293	2.391	1.610	0.526	4.035
VILIMAS_NOTCH1_TARGETS_UP VILIMAS_NOTCH1_TARGETS_UP	-0.513	-0.513	-0.513	-2.114	-0.301	-2.114	-0.513	-0.513	-0.513	1.818	7.385
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-0.228	-1.906	0.389	-1.157	-0.702	-1.906	-0.702	0.389	0.389	-0.411	8.259
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	0.594	0.768	-2.071	-0.552	-1.635	-0.982	-0.982	-0.982	-0.552	0.594	8.944
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	2.034	-0.981	-1.363	-1.868	-0.473	-0.981	-2.547	-0.981	0.831	2.034	4.241
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-3.375	-2.020	-0.442	-0.442	-0.913	-2.859	0.593	0.593	2.226	1.484	3.802
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.373	-0.373	-1.871	-1.871	-0.687	0.464	-1.486	-0.687	-0.373	1.194	8.650
WU_CELL_MIGRATION WU_CELL_MIGRATION	0.648	-1.061	-1.307	-1.307	-3.252	-0.301	-1.307	-0.301	0.799	1.584	6.432
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.982	-1.635	-1.276	-0.744	-0.282	-1.276	-1.635	-0.400	0.768	3.031	6.157
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	1.065	0.577	-0.975	-0.776	-1.211	-5.147	-0.608	-0.975	2.242	0.577	3.860
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-1.081	-0.521	-0.395	-0.521	-1.645	-1.081	-0.675	-0.395	-0.675	1.015	9.864
REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	3.079	-0.374	-1.301	-1.301	-0.374	-0.374	-0.374	-1.890	-1.890	0.388	5.302
PID_INTEGRIN1_PATHWAY PID_INTEGRIN1_PATHWAY	1.459	-0.859	-1.855	-0.859	-1.855	-0.566	-0.859	-1.271	0.846	1.132	5.409
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	1.861	-0.703	-2.951	-1.117	-0.893	-0.545	-1.691	-0.415	0.801	0.510	6.177
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-1.460	-0.280	-0.584	0.323	-1.918	-3.257	0.461	-1.460	2.608	1.905	2.616
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	0.384	-0.331	-1.765	-0.625	-2.217	-1.765	-2.217	0.677	1.067	2.795	3.555
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	2.182	-0.551	-2.677	-0.873	-2.265	-2.265	-0.551	0.278	0.892	2.182	3.055
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-2.216	-0.408	0.622	1.510	-1.044	-5.782	0.386	-0.528	0.622	1.104	2.823
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	1.601	-0.600	-1.466	-2.280	0.910	-0.600	-0.365	-2.280	-0.600	1.232	3.519
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-1.363	-0.473	-1.868	-1.363	0.289	-1.868	-0.981	0.289	1.367	2.034	4.765
KEGG_DILATED_CARDIOMYOPATHY KEGG_DILATED_CARDIOMYOPATHY	1.200	-0.377	-2.732	-2.031	-0.377	-0.377	-2.031	-0.247	-0.377	1.491	4.882
GROSS_HYPOXIA_VIA_ELK3_DN GROSS_HYPOXIA_VIA_ELK3_DN	-1.985	-1.029	-1.985	1.156	-1.296	-2.944	0.475	0.357	1.882	2.164	2.172
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	-1.015	-0.594	-0.594	0.522	-3.092	-3.092	-0.594	0.391	1.781	2.703	2.383
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	0.364	0.364	-1.221	-0.594	-3.900	-2.714	0.268	0.268	0.771	2.708	3.044
WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS	0.453	-1.057	-1.782	-1.782	0.254	1.040	0.254	-1.782	0.254	0.254	4.813
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	0.728	-1.677	-1.122	0.316	-1.122	-0.287	-1.122	-0.287	-1.677	1.325	5.982
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-0.521	-1.355	-2.364	-0.360	-1.355	0.524	-1.798	-0.360	0.707	2.813	4.128
REACTOME_ECM_PROTEOGLYCANS REACTOME_ECM_PROTEOGLYCANS	0.824	-0.775	-2.216	-0.523	-1.580	-0.775	-0.523	-1.117	0.265	3.908	3.416
HOLLERN_EMT_BREAST_TUMOR_UP HOLLERN_EMT_BREAST_TUMOR_UP	-0.430	-0.767	-0.996	-0.996	-0.996	-3.059	-1.273	1.074	1.814	1.545	3.869
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	0.898	-0.893	-0.893	-1.575	-1.575	-0.893	-0.500	-0.893	1.278	2.780	2.227
REACTOME_ELASTIC_FIBRE_FORMATION REACTOME_ELASTIC_FIBRE_FORMATION	0.654	-1.124	-1.124	-1.124	-1.865	-1.124	-0.676	-0.392	1.320	2.722	2.728
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION WP_HIPPOMERLIN_SIGNALING_DYSREGULATION	-0.255	-0.693	-0.510	-0.693	1.531	-3.156	-1.985	0.353	-0.510	0.644	5.382
KEGG_HEMATOPOIETIC_CELL_LINEAGE KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.435	0.289	-0.691	-0.981	-0.473	-0.691	-0.981	-1.868	0.289	-0.313	8.435
LINDSTEDT_DENDRITIC_CELL_MATURATION_C LINDSTEDT_DENDRITIC_CELL_MATURATION_C	-2.571	0.301	0.301	0.478	-2.571	-1.152	0.301	0.478	-0.762	0.970	4.016
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.647	0.519	-0.960	-1.998	-1.393	-1.998	-0.960	0.519	1.636	2.872	2.018
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	-1.006	0.845	-1.536	-0.645	-2.363	-1.536	-0.399	-0.235	0.845	2.339	2.826
REACTOME_MUSCLE_CONTRACTION REACTOME_MUSCLE_CONTRACTION	1.299	-0.408	-2.216	-1.859	-1.859	-0.843	-0.843	-0.309	1.739	0.926	4.147
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	0.326	-0.427	-0.633	-1.771	-1.280	-0.911	-0.911	-0.427	0.326	0.910	7.458
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-1.090	0.998	-0.650	-0.373	-1.823	-1.823	-0.373	-1.090	1.370	0.998	3.391
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	0.618	-1.423	-2.100	-3.011	-0.925	0.618	-0.436	-0.327	0.486	2.953	2.963
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.662	-1.044	-1.287	-1.287	-1.044	-2.280	-0.660	-0.293	1.177	2.114	4.408
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.276	0.328	-0.668	1.260	-2.944	-2.034	-0.668	-0.986	0.712	0.712	3.794
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	0.421	-1.173	-1.173	-0.541	0.421	-1.474	-1.831	0.310	-0.921	4.171	3.411
WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION	-0.365	0.637	-1.466	-1.466	-0.949	-0.365	-1.466	-0.600	-0.365	2.973	4.098
WP_GPCRS_OTHER WP_GPCRS_OTHER	0.456	-1.201	-0.875	-1.201	-0.432	1.653	-1.201	-0.432	-2.163	1.653	4.071
KEGG_FOCAL_ADHESION KEGG_FOCAL_ADHESION	-0.342	0.263	-0.725	-1.632	-3.205	-1.951	0.350	0.707	1.028	1.214	3.964
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	2.608	-0.280	-0.411	-1.918	-1.097	0.827	-1.460	-0.584	-1.918	0.629	3.422
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-1.606	-1.606	-0.691	-0.691	0.784	1.411	-0.260	-2.446	-0.260	1.411	2.682
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	-0.496	0.254	-0.904	-0.904	-1.956	-1.186	-1.532	0.500	0.500	2.496	4.509
LIANG_SILENCED_BY_METHYLATION_UP LIANG_SILENCED_BY_METHYLATION_UP	0.231	0.231	-0.733	-1.367	-1.367	1.130	-0.385	-0.733	-1.367	1.130	4.006
PLASARI_TGFB1_TARGETS_10HR_UP PLASARI_TGFB1_TARGETS_10HR_UP	1.739	0.386	-2.623	-0.843	-1.859	-1.548	-0.528	-0.528	0.766	1.299	3.456
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.277	-0.277	-1.009	-2.228	-1.009	-2.228	-0.490	0.326	0.691	3.075	3.418
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.762	0.701	-1.712	0.301	-0.301	-1.712	-1.152	-1.712	1.640	1.640	2.480
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-1.989	-0.451	0.571	-0.451	-0.451	-1.989	-0.755	-0.451	0.848	0.848	4.212
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	0.381	-0.368	-1.643	-3.235	0.772	-0.368	-0.819	-0.368	1.313	-0.368	3.763
BURTON_ADIPOGENESIS_9 BURTON_ADIPOGENESIS_9	-0.671	-1.835	0.301	-0.957	-1.835	-1.835	0.301	0.451	1.112	2.469	2.475
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	1.687	-0.637	-3.192	-1.073	0.359	0.257	-1.073	-1.073	0.628	0.482	4.053
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.830	-0.625	-0.331	0.273	-2.217	-3.439	0.273	0.273	1.830	1.830	2.137
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.279	-1.176	-0.854	0.472	-0.854	0.324	-0.606	-1.176	0.324	-0.606	7.498
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.361	-0.477	-0.834	0.482	-0.637	-2.116	-0.637	-1.073	2.261	0.985	4.053
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	1.900	-0.399	-1.536	-1.006	-1.006	-0.399	-1.006	-1.006	0.845	-0.235	4.501
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	0.275	0.651	0.275	-1.211	-0.810	-1.211	-2.654	-0.329	0.275	0.906	4.404
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	0.872	-1.273	-0.996	-1.607	-2.006	-0.580	-0.311	-0.580	2.103	0.872	3.478
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.555	-0.419	-0.419	-0.922	-1.445	-1.445	-0.722	-0.419	0.292	2.212	5.537
KHETCHOUMIAN_TRIM24_TARGETS_UP KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.411	-0.702	-0.702	0.389	-0.702	-1.906	-0.702	-1.157	0.920	1.677	3.798
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	1.074	0.403	-0.996	-0.996	-1.273	-2.484	-1.273	-0.430	0.872	2.414	2.422
REACTOME_O_LINKED_GLYCOSYLATION REACTOME_O_LINKED_GLYCOSYLATION	3.919	0.261	-0.929	-1.621	-1.237	-0.929	-0.493	0.261	-0.929	0.380	3.085
SEKI_INFLAMMATORY_RESPONSE_LPS_UP SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.577	-1.675	-0.842	-1.198	-0.577	-0.842	-0.577	-0.383	0.995	3.681	2.760
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	1.547	-0.329	-1.783	-1.211	-1.211	-0.810	-0.810	-0.527	0.275	2.349	2.814
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	0.883	-0.442	-1.308	-1.803	-0.652	0.657	-1.308	-0.652	-0.442	0.883	4.936
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	1.899	-0.521	-2.658	-0.521	-1.053	-1.053	0.256	-1.053	1.264	0.390	3.086
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.234	-0.234	-1.492	-1.492	-0.828	-0.828	-0.453	-0.453	0.646	2.977	2.394
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	-2.399	0.502	-1.252	0.339	-0.888	-1.252	-0.888	-0.266	1.856	0.937	3.079
NAKAJIMA_EOSINOPHIL NAKAJIMA_EOSINOPHIL	-0.222	0.398	-1.036	-1.036	-1.036	-0.491	-0.222	0.726	0.398	-1.036	4.470
HOELZEL_NF1_TARGETS_DN HOELZEL_NF1_TARGETS_DN	0.959	-1.077	-0.810	0.426	-0.597	-1.077	-2.318	-0.430	-0.597	2.369	3.512
GENTLES_LEUKEMIC_STEM_CELL_DN GENTLES_LEUKEMIC_STEM_CELL_DN	-0.787	-0.787	-0.787	-0.324	0.279	-0.787	-0.324	0.609	-0.787	0.609	4.787
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.320	-0.640	-0.640	-0.320	-0.320	-1.243	-1.243	-0.640	0.283	1.796	4.445
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	0.453	-1.034	0.453	-2.256	-0.567	-1.759	-0.281	-0.773	0.453	1.246	4.513
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	0.599	-1.117	-1.117	-0.775	-0.775	0.412	-1.580	-0.523	0.265	0.824	5.593
WP_GENES_CONTROLLING_NEPHROGENESIS WP_GENES_CONTROLLING_NEPHROGENESIS	-0.354	-1.057	-1.057	-1.782	-1.057	1.040	-0.354	0.453	-0.354	0.716	4.130
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	0.353	-0.397	-0.865	-2.362	0.353	-0.397	-1.707	-0.255	0.520	0.353	5.206
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	-0.578	-0.920	-0.920	-0.578	-1.431	-0.920	-0.348	0.258	0.944	0.664	5.489
PID_AVB3_INTEGRIN_PATHWAY PID_AVB3_INTEGRIN_PATHWAY	-0.314	-2.143	-1.064	0.445	-1.064	-1.517	-0.314	0.642	2.619	-0.314	2.625
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	1.367	-0.981	-2.547	-0.691	-0.313	-0.473	-0.473	-0.473	-0.691	1.082	4.241
REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE	-0.828	-0.351	-0.828	-0.351	-0.828	-0.828	-0.351	0.256	-0.351	3.671	2.152
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-1.397	0.272	-0.892	-0.556	-0.332	-2.197	-0.332	-0.556	1.706	0.980	3.142
RADMACHER_AML_PROGNOSIS RADMACHER_AML_PROGNOSIS	-0.442	1.439	-0.289	-0.289	-0.652	-3.443	-0.934	-0.442	-0.442	1.144	2.954
MCDOWELL_ACUTE_LUNG_INJURY_UP MCDOWELL_ACUTE_LUNG_INJURY_UP	-0.729	-0.431	-0.729	-0.729	-1.191	-1.191	-1.191	0.597	0.883	1.620	3.695
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-1.926	-0.390	-0.606	-0.606	-0.909	-0.909	-0.240	-0.606	0.560	1.728	4.605
LIM_MAMMARY_LUMINAL_MATURE_UP LIM_MAMMARY_LUMINAL_MATURE_UP	-0.702	-0.702	-1.649	-0.357	-0.950	-1.261	-0.507	-0.507	3.428	1.109	2.649
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	0.233	-1.501	-1.501	-0.977	1.551	0.397	0.233	-1.501	-0.622	1.191	2.901
ENGELMANN_CANCER_PROGENITORS_DN ENGELMANN_CANCER_PROGENITORS_DN	-0.252	0.357	-0.626	-0.935	1.029	-1.962	-1.362	-0.935	-0.405	1.681	3.436
WP_SLEEP_REGULATION WP_SLEEP_REGULATION	-0.266	-0.500	-0.266	-1.575	0.584	2.780	-1.575	-0.266	-0.500	-0.893	2.227
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	1.928	-0.336	-1.024	-1.740	-0.336	0.269	0.749	-0.599	-1.740	0.269	2.437
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	0.275	-0.527	-0.527	-1.783	0.275	-0.329	-1.783	-0.329	0.275	0.440	5.630
ELVIDGE_HYPOXIA_BY_DMOG_UP ELVIDGE_HYPOXIA_BY_DMOG_UP	-0.640	-2.246	-0.640	1.044	-1.415	-1.792	-0.640	1.522	0.840	1.044	2.100
WANG_METHYLATED_IN_BREAST_CANCER WANG_METHYLATED_IN_BREAST_CANCER	-1.450	-0.219	0.403	-1.450	-0.796	-0.430	-0.796	-0.430	1.030	0.680	3.747
MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD	0.997	0.737	-2.903	-0.647	-0.263	-1.393	-0.421	-0.647	-0.421	0.997	2.879
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	1.838	-0.755	-0.552	-1.013	0.333	0.628	-3.637	-0.552	-0.271	0.333	2.878
REACTOME_GAP_JUNCTION_ASSEMBLY REACTOME_GAP_JUNCTION_ASSEMBLY	0.898	-1.575	-1.575	-0.893	-0.266	0.898	-0.893	-0.266	-0.266	0.339	3.397
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	-0.392	-1.124	-1.124	0.226	0.226	-0.676	-0.676	-0.676	-0.676	3.288	3.294
HUANG_FOXA2_TARGETS_DN HUANG_FOXA2_TARGETS_DN	-0.266	0.339	-0.266	-0.893	-0.500	-0.893	-0.893	-1.575	1.721	-0.266	4.060
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	1.508	-1.925	-0.813	-1.280	-0.634	0.574	-0.813	-1.578	1.282	0.722	2.920
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	1.138	0.889	-2.807	-0.589	0.337	-0.833	-0.589	-0.833	-1.151	1.138	2.852
LEE_AGING_CEREBELLUM_UP LEE_AGING_CEREBELLUM_UP	-1.280	-0.427	0.484	0.326	-0.633	-0.277	0.679	-2.436	-0.277	-0.633	5.024
REACTOME_DISEASES_OF_GLYCOSYLATION REACTOME_DISEASES_OF_GLYCOSYLATION	1.749	-0.453	-0.608	-1.317	-0.608	-1.656	-0.330	-1.317	-0.453	1.749	3.379
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	0.642	-1.064	-1.064	-0.731	-0.731	0.289	-1.517	-0.488	0.289	0.878	5.197
HARRIS_BRAIN_CANCER_PROGENITORS HARRIS_BRAIN_CANCER_PROGENITORS	0.453	0.453	-0.354	-1.782	-1.782	0.254	-1.057	-0.624	0.254	1.862	2.358
CROMER_TUMORIGENESIS_DN CROMER_TUMORIGENESIS_DN	-0.782	-0.782	-1.259	-0.782	1.137	0.334	-0.270	-2.031	0.546	0.546	3.498
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	-0.489	-1.712	-0.301	-0.489	-0.762	-2.571	0.970	0.301	0.701	0.701	2.956
SAFFORD_T_LYMPHOCYTE_ANERGY SAFFORD_T_LYMPHOCYTE_ANERGY	-1.077	-0.364	0.246	0.246	-1.476	-1.998	-0.771	-0.538	1.231	1.856	3.026
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.486	-2.276	-0.486	-0.352	-0.486	-1.439	-0.352	0.255	-0.352	2.056	4.266
TSAI_RESPONSE_TO_IONIZING_RADIATION TSAI_RESPONSE_TO_IONIZING_RADIATION	-1.857	0.864	-0.939	-0.554	-1.857	-1.497	-0.413	0.540	1.059	2.047	2.054
WP_HUMAN_COMPLEMENT_SYSTEM WP_HUMAN_COMPLEMENT_SYSTEM	-0.714	-0.984	-2.331	-0.714	0.728	0.384	-0.984	-0.506	0.259	3.282	2.121
GAJATE_RESPONSE_TO_TRABECTEDIN_UP GAJATE_RESPONSE_TO_TRABECTEDIN_UP	-1.271	0.405	0.250	-0.566	-1.855	-0.859	-0.359	-0.359	0.250	0.604	5.409
HOWLIN_PUBERTAL_MAMMARY_GLAND HOWLIN_PUBERTAL_MAMMARY_GLAND	-1.301	-0.374	-1.890	0.581	-0.374	0.818	-0.374	-1.301	-0.586	0.818	4.130
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	-0.702	-1.157	-0.411	0.920	-0.702	-0.228	-1.906	-0.702	-0.228	2.134	2.646
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	-0.283	-0.925	-0.525	-1.616	0.320	0.858	-0.925	-1.616	0.858	1.226	2.148
PID_INTEGRIN_CS_PATHWAY PID_INTEGRIN_CS_PATHWAY	0.684	-0.520	-1.077	-0.520	0.371	-1.077	-1.077	-0.520	-0.241	1.088	3.512
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	2.511	1.005	0.395	-1.779	-1.162	-0.922	-1.779	-0.419	-0.555	0.395	2.520
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	0.420	0.563	-1.022	-1.022	-1.322	-1.022	-1.687	-0.424	0.731	2.246	2.943
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	0.564	0.440	-0.790	-1.507	-0.790	0.440	-2.202	-0.992	-0.270	2.210	3.126
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.507	-1.528	-1.528	-1.528	-0.828	-0.398	-0.828	0.396	2.275	0.944	2.860
ROSS_AML_WITH_AML1_ETO_FUSION ROSS_AML_WITH_AML1_ETO_FUSION	-0.819	1.025	-0.819	0.243	-1.643	-2.289	-0.368	-0.368	1.025	0.558	3.277
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-0.260	-0.822	-0.635	-0.260	-1.048	-3.594	-0.358	0.463	2.428	0.599	2.138
RAMALHO_STEMNESS_DN RAMALHO_STEMNESS_DN	-1.064	1.153	-1.064	0.445	-0.314	-3.069	-0.731	-0.314	0.878	0.642	2.206
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	-0.247	-0.663	-0.663	-0.663	-0.663	-0.247	-0.663	0.762	0.362	-0.247	4.522
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	1.351	-0.515	-1.428	-0.682	-0.682	-0.886	-0.682	-1.428	0.329	3.132	2.159
WP_INFLAMMATORY_RESPONSE_PATHWAY WP_INFLAMMATORY_RESPONSE_PATHWAY	0.231	-0.385	-0.733	-0.733	-0.733	0.754	0.231	-1.367	-0.733	0.453	4.756
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	1.971	-0.412	-1.661	-1.661	-0.412	-0.761	-0.566	-0.566	-0.292	0.749	3.774
CHIBA_RESPONSE_TO_TSA_UP CHIBA_RESPONSE_TO_TSA_UP	-1.293	-0.492	-1.293	-0.809	-0.809	-0.285	-0.285	-0.285	1.877	0.317	3.999
NABA_COLLAGENS NABA_COLLAGENS	1.370	-0.650	-0.650	-0.650	-0.650	0.239	-1.090	-1.090	0.430	-0.373	4.684
REACTOME_COLLAGEN_CHAIN_TRIMERIZATION REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	1.370	-0.650	-0.650	-0.650	-0.650	0.239	-1.090	-1.090	0.430	-0.373	4.684
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING	-0.357	-1.261	-1.261	-0.702	-0.507	-0.702	-0.507	-0.507	0.511	1.644	4.790
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.490	-1.093	-1.093	-0.360	-1.093	0.964	-1.093	-1.384	0.964	2.538	2.232
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	-0.671	-0.457	-0.457	-0.301	-0.457	-0.957	-1.335	-1.335	1.112	1.112	4.319
HUPER_BREAST_BASAL_VS_LUMINAL_DN HUPER_BREAST_BASAL_VS_LUMINAL_DN	0.362	-0.668	-1.571	-0.668	-0.668	-0.668	-0.416	-0.247	-0.668	2.747	3.264
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	1.859	-0.324	-1.709	-1.277	-0.677	0.576	-0.677	-0.940	-0.677	0.997	2.985
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	0.920	-0.702	-0.702	-0.411	-1.157	-0.228	-1.157	-0.411	-0.702	0.920	4.440
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	-0.733	-1.367	-0.385	0.231	0.231	-0.733	-0.733	0.231	3.306	-0.733	2.096
BROWNE_HCMV_INFECTION_2HR_UP BROWNE_HCMV_INFECTION_2HR_UP	0.302	0.527	-1.658	0.302	-0.300	-0.549	-0.549	-0.549	-1.658	1.594	2.604
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.875	-0.562	-2.290	0.270	-1.095	-0.888	-1.095	-0.437	0.584	2.151	2.716
LEE_LIVER_CANCER_E2F1_UP LEE_LIVER_CANCER_E2F1_UP	-0.786	-0.786	-0.786	-0.315	0.288	-1.181	-0.786	-0.786	1.982	0.459	3.927
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	0.541	-1.064	-0.691	-0.260	-0.691	-1.606	-1.606	1.075	0.541	0.541	3.184
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-0.471	0.814	-0.471	0.334	-2.031	-1.259	-0.782	-0.782	1.137	0.814	2.416
AMIT_SERUM_RESPONSE_60_MCF10A AMIT_SERUM_RESPONSE_60_MCF10A	-0.668	0.564	-1.571	-0.668	-0.416	-2.404	0.362	0.362	0.362	1.456	2.281
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	-0.610	-0.610	-0.610	0.928	-0.610	0.302	-0.300	-0.610	-1.201	0.302	4.606
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	0.435	-1.363	-1.363	-1.363	0.831	-1.363	-0.473	-0.313	0.615	1.684	2.422
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	-0.687	-0.687	-1.167	-0.512	0.464	-2.335	0.464	0.464	0.464	-0.265	4.577
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	1.933	0.292	-2.627	-0.310	0.395	-1.445	-1.162	0.292	0.660	-0.555	2.520
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	0.332	-0.704	-0.704	-0.704	-0.272	-0.704	0.332	-0.704	-0.272	1.821	2.545
PID_PI3KCI_PATHWAY PID_PI3KCI_PATHWAY	-1.225	0.351	0.351	-0.256	-0.755	-1.989	1.180	-1.225	1.180	-0.256	2.005
LEE_LIVER_CANCER_SURVIVAL_UP LEE_LIVER_CANCER_SURVIVAL_UP	-0.714	0.479	-1.114	-0.714	-1.658	-0.898	-0.326	-0.714	3.157	0.751	2.267
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	-0.860	-0.860	-0.860	0.359	-0.477	0.940	-0.477	-0.250	-1.533	1.332	2.881
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	0.362	-0.663	-0.663	-0.663	0.362	0.762	-0.663	-0.663	0.762	-0.663	2.699
WORSCHECH_TUMOR_REJECTION_UP WORSCHECH_TUMOR_REJECTION_UP	-0.301	0.301	-0.762	0.970	-0.489	0.301	-0.762	-2.571	-0.489	0.478	3.468
GAURNIER_PSMD4_TARGETS GAURNIER_PSMD4_TARGETS	0.328	-0.668	-0.668	-0.438	-2.034	0.328	-0.438	-0.986	0.328	0.966	4.332
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	-0.455	-0.455	-0.455	0.187	-0.455	-0.455	0.187	-0.455	1.148	-0.455	3.765
ZHAN_MULTIPLE_MYELOMA_SPIKED ZHAN_MULTIPLE_MYELOMA_SPIKED	0.772	1.214	-0.994	-0.994	-0.462	-0.462	-0.462	-0.994	-0.462	0.772	2.361
SWEET_KRAS_ONCOGENIC_SIGNATURE SWEET_KRAS_ONCOGENIC_SIGNATURE	-1.053	-1.053	0.256	0.995	0.256	-2.658	-1.053	1.264	0.390	0.390	2.269
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	-0.652	-0.360	-1.384	-0.360	-0.851	-0.851	-0.360	-1.384	1.404	1.657	3.235
REACTOME_P2Y_RECEPTORS REACTOME_P2Y_RECEPTORS	0.167	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	0.524	0.167	0.167	4.578
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	0.265	-0.775	1.724	-1.117	-1.580	-1.580	-0.523	0.599	-0.341	0.824	2.508
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	0.731	0.563	-0.581	0.301	-0.778	-1.687	-1.687	-1.022	-0.301	1.647	2.943
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.647	-0.263	-0.421	1.297	-0.421	-1.998	-0.960	-1.393	0.519	1.297	2.431
SEKI_INFLAMMATORY_RESPONSE_LPS_DN SEKI_INFLAMMATORY_RESPONSE_LPS_DN	0.217	-0.911	-0.911	-0.406	-0.406	-0.911	0.217	-0.406	0.491	0.491	4.165
REACTOME_SIGNALING_BY_PDGF REACTOME_SIGNALING_BY_PDGF	0.564	0.814	-1.035	-0.416	-2.404	-1.035	0.362	-0.668	-0.247	1.112	2.281
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	1.023	-0.505	-1.420	-0.730	-0.338	0.576	0.267	-1.420	-1.420	1.023	3.148
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	-1.077	-0.241	-1.077	-0.520	-0.241	0.371	0.371	-1.077	-0.241	0.684	3.512
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	1.244	-0.508	-1.748	-1.181	-1.181	-0.786	-0.315	-0.315	0.938	0.938	2.417
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	0.539	0.283	-1.243	-0.640	-0.320	0.283	-1.243	-1.243	0.881	0.539	2.365
LENAOUR_DENDRITIC_CELL_MATURATION_UP LENAOUR_DENDRITIC_CELL_MATURATION_UP	-0.582	0.593	-1.055	-0.291	-0.417	-2.287	-1.055	0.439	0.439	0.593	3.997
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	-0.223	-0.621	-0.621	-0.223	-0.621	-0.621	0.396	-0.621	-0.223	0.823	3.775
FURUKAWA_DUSP6_TARGETS_PCI35_UP FURUKAWA_DUSP6_TARGETS_PCI35_UP	-0.471	0.907	-2.107	-0.471	0.301	-0.710	-1.486	0.907	-0.471	0.463	3.146
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	-0.260	-1.064	-1.064	-0.434	-2.446	-0.260	-0.260	0.346	0.784	1.411	2.219
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	-0.671	0.264	-0.671	0.264	-1.284	-0.671	-0.671	-0.671	0.836	0.836	3.558
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	-1.450	0.680	-0.219	-0.430	-0.796	-1.450	1.449	-0.219	-0.219	-0.430	2.483
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.086	-0.482	-0.343	-1.164	-1.164	-0.343	-0.885	-0.885	-0.661	1.886	3.294
REACTOME_CELL_CELL_COMMUNICATION REACTOME_CELL_CELL_COMMUNICATION	-0.813	-0.813	-0.813	-1.368	-0.610	-1.063	-0.448	0.396	1.864	1.326	2.850
REACTOME_COLLAGEN_DEGRADATION REACTOME_COLLAGEN_DEGRADATION	0.440	-0.527	-1.211	-1.211	-1.211	0.440	-0.527	-0.527	1.205	0.275	3.840
MIKKELSEN_ES_HCP_WITH_H3K27ME3 MIKKELSEN_ES_HCP_WITH_H3K27ME3	0.285	0.501	-0.991	-0.318	0.501	1.535	-1.699	-0.574	-0.991	-0.574	2.519
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	1.097	0.238	-0.884	-0.586	-0.884	-0.586	-1.301	0.238	0.238	-0.374	4.700
REACTOME_SURFACTANT_METABOLISM REACTOME_SURFACTANT_METABOLISM	0.539	0.539	-1.243	-0.640	0.283	-0.320	-1.243	-0.320	0.283	-0.640	3.690
REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE	0.527	-0.870	-0.870	-0.870	-0.378	-0.378	-0.870	0.527	0.527	0.527	2.729
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.998	-1.054	-0.817	-1.054	-0.340	-0.465	-1.681	0.265	-0.340	0.814	2.969
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.298	0.304	-0.745	-0.298	-0.745	-0.745	0.304	-0.745	-0.298	1.128	3.187
BROWNE_HCMV_INFECTION_18HR_DN BROWNE_HCMV_INFECTION_18HR_DN	-0.401	-0.524	-0.673	-0.524	0.399	-2.306	-0.851	-0.524	0.514	1.825	3.291
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.751	-0.351	-0.351	0.390	-1.053	-1.966	-0.351	0.390	-0.521	0.995	4.016
